Effect of ovarian steroids on hypothalamic norepinephrine-induced adenylate cyclase activity.
The adenylate cyclase activity induced by norepinephrine (10(-8)-10(-9) M) was studied in hypothalamic particulate fractions from female rats. The effect of estradiol on this activity was studied in rats that were ovariectomized in diestrus 1, injected with estradiol benzoate (50 micrograms/kg body weight), and killed 48 h later. The effect of progesterone was studied in fractions from female cycling rats injected in the morning of diestrus 2 with progesterone (2 mg/rat); these animals were killed 30 or 48 h after the steroid injection. The blockade of norepinephrine-induced adenylate cyclase activity by alpha- and beta-blocking agents (10(-8)-10(-9) M) was also evaluated. The enzymatic activity was determined by monitoring the capacity to produce cAMP from ATP at saturated levels; cAMP was assayed by radioimmunoassay. At 48 h after administration, estradiol benzoate increased the norepinephrine-induced adenylate cyclase activity in the hypothalamus. This effect was not changed by the presence of phenoxybenzamine, an alpha-adrenoceptor blocker, but was greatly reduced by propranolol, the beta-adrenoreceptor blocker. In contrast, the progesterone, at 30 and 48 h after injection, decreased the hypothalamic adenylate cyclase activity, and this effect was preferentially antagonized in the presence of phenoxybenzamine rather than propranolol. These results suggest that estrogen and progesterone act selectively on one or another type of adrenergic receptor at the hypothalamic level.
Zubin
P
P
Laboratorio de Nucleotidos Ciclicos, Facultad de Ciencias Medicas, Universidad Nacional de Cordoba, Argentina.
Defagot
C
C
D000262:Adenylyl Cyclases / Q000096:biosynthesis*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D004305:Dose-Response Relationship, Drug; D004790:Enzyme Induction / Q000187:drug effects; D004958:Estradiol / Q000494:pharmacology*; D004971:Estrus / Q000502:physiology; D005260:Female; D007031:Hypothalamus / Q000187:drug effects / Q000201:enzymology*; D009638:Norepinephrine / Q000494:pharmacology*; D010052:Ovariectomy; D011374:Progesterone / Q000494:pharmacology*; D051381:Rats
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D011374:Progesterone; D004958:Estradiol; D000262:Adenylyl Cyclases; D009638:Norepinephrine